Cargando…
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
New therapeutic targets are a valuable resource for treatment of SARS-CoV-2 viral infection. Genome-wide association studies have identified risk loci associated with COVID-19, but many loci are associated with comorbidities and are not specific to host–virus interactions. Here, we identify and expe...
Autores principales: | Moll, Tobias, Odon, Valerie, Harvey, Calum, Collins, Mark O, Peden, Andrew, Franklin, John, Graves, Emily, Marshall, Jack NG, dos Santos Souza, Cleide, Zhang, Sai, Castelli, Lydia, Hautbergue, Guillaume, Azzouz, Mimoun, Gordon, David, Krogan, Nevan, Ferraiuolo, Laura, Snyder, Michael P, Shaw, Pamela J, Rehwinkel, Jan, Cooper-Knock, Johnathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585911/ https://www.ncbi.nlm.nih.gov/pubmed/36241425 http://dx.doi.org/10.26508/lsa.202201449 |
Ejemplares similares
-
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
por: Moll, Tobias, et al.
Publicado: (2022) -
Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease
por: Gatto, Noemi, et al.
Publicado: (2020) -
Integrated Bioinformatic Investigation of EXOSCs in Hepatocellular Carcinoma Followed by the Preliminary Validation of EXOSC5 in Cell Proliferation
por: Zhang, Yujing, et al.
Publicado: (2022) -
SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis
por: Castelli, Lydia M., et al.
Publicado: (2021) -
Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome
por: Chandran, Jayanth S., et al.
Publicado: (2017)